Delivery Order SPE2DB24D3013-SPE2DB24FFFPM

Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Concerta ER 27 mg tablets. The contract, valued at $3,647.44, is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award, valued at $3,605.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Concerta ER 27 mg tablets, a prescription medication, to support the Department of Defense (DoD) and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of Concerta ER 27 mg tablets. The contract, valued at $10,384.68, is a Firm Fixed Price Delivery Order with a completion date of June 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of Concerta ER 54 mg tablets worth $44,919.74. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a completion date of May 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The award, valued at $19,205.87, is for the delivery of 4,564,881,167 units of Concerta ER 36 mg tablets. The contract is a firm fixed-price delivery order with a completion date of June 12, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of CONCERTA ER 27 MG TABLET 100S, a prescription medication. The fixed-price delivery order, valued at $5,371.80, has a completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division was issued by the Defense Logistics Agency (DLA) for the delivery of Concerta ER 54 mg tablets. The contract, valued at $10,070.99, is a firm-fixed price delivery order that runs through June 24, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Veterans...
This federal contract award is for the delivery of Concerta ER 18 mg tablets from Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $6,628.67 and an ultimate completion date of May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $3,383.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564616935 Concerta ER 18 mg tablets in lots of 100 through May 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds several indefinite delivery contracts (IDCs) with the federal government to supply a wide range of medical products and prescription drugs. This includes a...
This federal contract award, valued at $24,818.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Concerta ER 18 mg tablets, with a completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFFPM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a leading pharmaceutical distributor, for the delivery of Concerta ER 18 mg tablets. The contract has a firm-fixed price of $6,789.98 and an ultimate completion date of May 30, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen's extensive experience and capabilities in pharmaceutical distribution and government contracting have enabled it to secure these lucrative contracts with federal agencies, supporting the medical needs of the U.S. military and other government entities.

Generated 8/28/24, 11:54 AM